- Home
- VOC vs MAIA Comparison
VOC vs MAIA Comparison
Compare VOC & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOC
- MAIA
- Stock Information
- Founded
- VOC 2010
- MAIA 2018
- Country
- VOC United States
- MAIA United States
- Employees
- VOC N/A
- MAIA N/A
- Industry
- VOC Oil & Gas Production
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- VOC Energy
- MAIA Health Care
- Exchange
- VOC Nasdaq
- MAIA Nasdaq
- Market Cap
- VOC 48.6M
- MAIA 46.7M
- IPO Year
- VOC 2011
- MAIA 2022
- Fundamental
- Price
- VOC $3.02
- MAIA $1.76
- Analyst Decision
- VOC
- MAIA
- Analyst Count
- VOC 0
- MAIA 0
- Target Price
- VOC N/A
- MAIA N/A
- AVG Volume (30 Days)
- VOC 69.0K
- MAIA 535.2K
- Earning Date
- VOC 01-01-0001
- MAIA 08-08-2025
- Dividend Yield
- VOC 20.76%
- MAIA N/A
- EPS Growth
- VOC N/A
- MAIA N/A
- EPS
- VOC 0.63
- MAIA N/A
- Revenue
- VOC $11,917,424.00
- MAIA N/A
- Revenue This Year
- VOC N/A
- MAIA N/A
- Revenue Next Year
- VOC N/A
- MAIA N/A
- P/E Ratio
- VOC $4.70
- MAIA N/A
- Revenue Growth
- VOC N/A
- MAIA N/A
- 52 Week Low
- VOC $2.44
- MAIA $1.40
- 52 Week High
- VOC $5.69
- MAIA $4.24
- Technical
- Relative Strength Index (RSI)
- VOC 59.20
- MAIA 56.41
- Support Level
- VOC $2.82
- MAIA $1.80
- Resistance Level
- VOC $2.93
- MAIA $2.15
- Average True Range (ATR)
- VOC 0.10
- MAIA 0.13
- MACD
- VOC 0.02
- MAIA 0.02
- Stochastic Oscillator
- VOC 88.14
- MAIA 60.00
About VOC VOC Energy Trust Units of Beneficial Interest
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.